Dr Joshua Casan
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
42 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Refinement of the classification of DDX41 variants through analysis of aggregated clinical datasets
DOI: 10.1038/s41375-026-02886-62026
Journal article
Relapsed/refractory mycosis fungoides and Sezary syndrome: biology, clinical manifestations and therapeutic options
DOI: 10.1080/10428194.2025.25986622026
Journal article
Innovative approaches for managing relapsed or refractory peripheral T-cell lymphoma
DOI: 10.1080/14656566.2026.26673262025
Conference Proceedings
Development of a novel CAR-T cell therapy using a multimodal approach to target T cell lymphoma
DOI: 10.1182/blood-2025-41122025
Journal article
Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision Therapeutics
DOI: 10.3390/jpm151105602025
Journal article
Marked Erythroblast Haemophagocytosis in Association With Immunotherapy for Metastatic Melanoma.
DOI: 10.1002/jha2.700692025
Journal article
Efficient mRNA delivery to resting T cells to reverse HIV latency
DOI: 10.1038/s41467-025-60001-2
RECENT SCHOLARLY WORKS
2025
Journal article
Heterozygous germline TET2 loss-of-function variants associated with an ALPS-like phenotype
DOI: 10.1111/bjh.200422025
Journal article
Immune pathways, current and potential therapies in Mycosis fungoides and Sezary syndrome
DOI: 10.1080/1744666X.2025.25333672025
Journal article
Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial
DOI: 10.1016/S2352-3026(24)00317-X